✦ LIBER ✦

Differential induction of androgen receptor transactivation by different androgen receptor coativators in human prostate cancer DU 145 cells

✍ Scribed by Shuyuan Yeh; Hong-Yo Kang; Hiroshi Miyamoto; Kazuo Nishimura; Hong-Chiang Chang; Huei-Ju Ting; Mujib Rahman; Hui-Kuan Lin; Naohiro Fujimoto; Yueh-Chiang Hu; Atsushi Mizokami; Ko-En Huang; Chawnshang Chang

Book ID: 111637495
Publisher: Springer
Year: 1999
Tongue: English
Weight: 196 KB
Volume: 11
Category: Article
ISSN: 0969-711X
DOI: 10.1385/endo:11:2:195

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential transactivation by the andr

Differential transactivation by the androgen receptor in prostate cancer cells

✍ Snoek, Robert; Bruchovsky, Nicholas; Kasper, Susan; Matusik, Robert J.; Gleave, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

## BACKGROUND. The purpose of this study was to determine the contribution of different transactivating regions of the androgen receptor (AR) to the induction of androgen-regulated promoters in poorly (PC3 cells) and well-differentiated (LNCaP cells) prostate cancer cell lines. METHODS. PC3 and LN

Differential androgen receptor signals i

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

✍ Niu, Y; Chang, T-M; Yeh, S; Ma, W-L; Wang, Y Z; Chang, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 810 KB

DU-145 and PC-3 human prostate cancer ce

DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation

✍ Fatouma Alimirah; Jianming Chen; Zane Basrawala; Hong Xin; Divaker Choubey 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Retinoblastoma, a Tumor Suppressor, Is a

Retinoblastoma, a Tumor Suppressor, Is a Coactivator for the Androgen Receptor in Human Prostate Cancer DU145 Cells

✍ Shuyuan Yeh; Hiroshi Miyamoto; Kazuo Nishimura; Hongyo Kang; John Ludlow; Peiwen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Vasoactive intestinal peptide (VIP) enha

Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR)

✍ Osamu Nagakawa; Jun Murata; Akira Junicho; Tadashi Matsuda; Yasuyoshi Fujiuchi; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 138 KB

The PPARγ ligand ciglitazone regulates a

The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells

✍ Patrice E. Moss; Besstina E. Lyles; LaMonica V. Stewart 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 989 KB